Chairman, President & CEO

Chief Financial Officer

Boston Scientific to acquire California bladder dysfunction treatment company

Boston Scientific snaps up Valencia Technologies to bolster urology offerings

Boston Scientific to acquire Valencia Technologies, terms not disclosed

Venous Stents Market Size to Reach USD 2.57 Billion by 2033, Driven by Rising Chronic Venous Disease Burden – SNS Insider

0.8571428656578064

Commercial Strategy & Excellence Analyst III

Boston Scientific is a leader in medical science, dedicated to transforming the lives of patients through innovative solutions. The Commercial Strategy & Excellence Analyst III will provide analytical support to business initiatives, focusing on process improvement and operational execution within the Endoscopy division.

Commercial Strategy & Excellence Analyst III - Endo

President and Chief Executive Officer

Senior Director, AI Platforms & Solutions

AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies

If You Invested $1000 In Cencora Stock 5 Years Ago, You Would Have This Much Today

Drug Distributors Poised for Growth Amid Emerging Risks, BofA Says

Cencora to fast-track OneOncology buyout in $7.4bn deal

0.4285714328289032

Commercial Finance Strategy Analyst II

Cencora is an innovative company focused on creating healthier futures. They are seeking a self-driven Finance professional to develop commercial offerings and collaborate with various teams to forecast sales trends and profitability in the healthcare industry.

Cencora is committed to creating healthier futures and seeks a self-driven Finance professional to join their commercial underwriting finance team. The role involves developing financial models, collaborating with various teams, and providing financial support to drive profitability for national healthcare providers.